Stephen T. Gately

Translational Drug Development LLC engages in the provision of innovative services for oncology-focused companies. It offers preclinical, bioanalytical, regulatory, and clinical services. The company was founded in 2003 and is headquartered in Scottsdale, AZ.

Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses

NeoPharm, Inc. engages in the research, development, and commercialization of drugs for the treatment of various cancers and other diseases. The company has built its drug development program around two proprietary technology platforms, a tumor-targeting toxin platform which includes development for a new indication of Pulmonary Fibrosis, and a novel NeoLipid liposomal drug delivery system. It has advanced five drug product candidates in various stages of clinical and pre clinical development for the treatment of cancer and one drug product candidate in pre-clinical development for treatment of interstitial pulmonary fibrosis and asthma. NeoPharm was founded in May 15, 1900and is headquartered in Lake Bluff, IL.

Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL.

Silamed, Inc. manufactures and markets pharmaceutical products. Its products include Silexyn, a silicon medicinal drug for cancer treatment and silicon derivatives. The firm offers drug discovery and development and non-oncology applications development services. The company was founded by Stephen T. Gatley and Stephen P. Wanaski in 2003 and is headquartered in Scottsdale, AZ.